Selected research
Market Structure
Global Passive Temperature Controlled Packaging in Pharma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Passive Temperature Controlled Packaging in Pharma market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Passive Temperature Controlled Packaging in Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Passive Temperature Controlled Packaging in Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Passive Temperature Controlled Packaging in Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Passive Temperature Controlled Packaging in Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Passive Temperature Controlled Packaging in Pharma include Sonoco ThermoSafe, Hazgo, Cold Chain Technologies, Marken and Jarden Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Passive Temperature Controlled Packaging in Pharma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Passive Temperature Controlled Packaging in Pharma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Passive Temperature Controlled Packaging in Pharma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Passive Temperature Controlled Packaging in Pharma market size, projected growth trends, production technologies, key applications, and end-use industries.
Passive Temperature Controlled Packaging in Pharma Segment by Company
Sonoco ThermoSafe
Hazgo
Cold Chain Technologies
Marken
Jarden Life Sciences
Passive Temperature Controlled Packaging in Pharma Segment by Type
Insulated Boxes
Insulated Containers
Other
Passive Temperature Controlled Packaging in Pharma Segment by Application
Pharma Industry
Others
Passive Temperature Controlled Packaging in Pharma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Passive Temperature Controlled Packaging in Pharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Passive Temperature Controlled Packaging in Pharma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Passive Temperature Controlled Packaging in Pharma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Passive Temperature Controlled Packaging in Pharma market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Passive Temperature Controlled Packaging in Pharma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Passive Temperature Controlled Packaging in Pharma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Passive Temperature Controlled Packaging in Pharma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Insulated Boxes
- Insulated Containers
- Other
Applications
- Pharma Industry
- Others
Companies covered
- Sonoco ThermoSafe
- Hazgo
- Cold Chain Technologies
- Marken
- Jarden Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Passive Temperature Controlled Packaging in Pharma Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Passive Temperature Controlled Packaging in Pharma Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Passive Temperature Controlled Packaging in Pharma Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Passive Temperature Controlled Packaging in Pharma Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Passive Temperature Controlled Packaging in Pharma Market Dynamics
- 2.1 Passive Temperature Controlled Packaging in Pharma Industry Trends
- 2.2 Passive Temperature Controlled Packaging in Pharma Industry Drivers
- 2.3 Passive Temperature Controlled Packaging in Pharma Industry Opportunities and Challenges
- 2.4 Passive Temperature Controlled Packaging in Pharma Industry Restraints
3 Passive Temperature Controlled Packaging in Pharma Market by Manufacturers
- 3.1 Global Passive Temperature Controlled Packaging in Pharma Revenue by Manufacturers (2021-2026)
- 3.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Manufacturers (2021-2026)
- 3.3 Global Passive Temperature Controlled Packaging in Pharma Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Passive Temperature Controlled Packaging in Pharma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Passive Temperature Controlled Packaging in Pharma Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Passive Temperature Controlled Packaging in Pharma Manufacturers, Product Type & Application
- 3.7 Global Passive Temperature Controlled Packaging in Pharma Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Passive Temperature Controlled Packaging in Pharma Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Passive Temperature Controlled Packaging in Pharma Players Market Share by Revenue in 2025
- 3.8.3 2025 Passive Temperature Controlled Packaging in Pharma Tier 1, Tier 2, and Tier 3
4 Passive Temperature Controlled Packaging in Pharma Market by Type
- 4.1 Passive Temperature Controlled Packaging in Pharma Type Introduction
- 4.1.1 Insulated Boxes
- 4.1.2 Insulated Containers
- 4.1.3 Other
- 4.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Type
- 4.2.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Type (2021-2032)
- 4.2.3 Global Passive Temperature Controlled Packaging in Pharma Sales Market Share by Type (2021-2032)
- 4.3 Global Passive Temperature Controlled Packaging in Pharma Revenue by Type
- 4.3.1 Global Passive Temperature Controlled Packaging in Pharma Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Passive Temperature Controlled Packaging in Pharma Revenue by Type (2021-2032)
- 4.3.3 Global Passive Temperature Controlled Packaging in Pharma Revenue Market Share by Type (2021-2032)
5 Passive Temperature Controlled Packaging in Pharma Market by Application
- 5.1 Passive Temperature Controlled Packaging in Pharma Application Introduction
- 5.1.1 Pharma Industry
- 5.1.2 Others
- 5.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Application
- 5.2.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Application (2021-2032)
- 5.2.3 Global Passive Temperature Controlled Packaging in Pharma Sales Market Share by Application (2021-2032)
- 5.3 Global Passive Temperature Controlled Packaging in Pharma Revenue by Application
- 5.3.1 Global Passive Temperature Controlled Packaging in Pharma Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Passive Temperature Controlled Packaging in Pharma Revenue by Application (2021-2032)
- 5.3.3 Global Passive Temperature Controlled Packaging in Pharma Revenue Market Share by Application (2021-2032)
6 Global Passive Temperature Controlled Packaging in Pharma Sales by Region
- 6.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Region (2021-2032)
- 6.2.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Region (2021-2026)
- 6.2.2 Global Passive Temperature Controlled Packaging in Pharma Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Passive Temperature Controlled Packaging in Pharma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Passive Temperature Controlled Packaging in Pharma Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Passive Temperature Controlled Packaging in Pharma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Passive Temperature Controlled Packaging in Pharma Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Passive Temperature Controlled Packaging in Pharma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Passive Temperature Controlled Packaging in Pharma Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Passive Temperature Controlled Packaging in Pharma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Passive Temperature Controlled Packaging in Pharma Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Passive Temperature Controlled Packaging in Pharma Revenue by Region
- 7.1 Global Passive Temperature Controlled Packaging in Pharma Revenue by Region
- 7.1.1 Global Passive Temperature Controlled Packaging in Pharma Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Passive Temperature Controlled Packaging in Pharma Revenue by Region (2021-2026)
- 7.1.3 Global Passive Temperature Controlled Packaging in Pharma Revenue by Region (2027-2032)
- 7.1.4 Global Passive Temperature Controlled Packaging in Pharma Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Passive Temperature Controlled Packaging in Pharma Revenue (2021-2032)
- 7.2.2 North America Passive Temperature Controlled Packaging in Pharma Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Passive Temperature Controlled Packaging in Pharma Revenue (2021-2032)
- 7.3.2 Europe Passive Temperature Controlled Packaging in Pharma Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Passive Temperature Controlled Packaging in Pharma Revenue (2021-2032)
- 7.4.2 Asia-Pacific Passive Temperature Controlled Packaging in Pharma Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Passive Temperature Controlled Packaging in Pharma Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Passive Temperature Controlled Packaging in Pharma Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sonoco ThermoSafe
- 8.1.1 Sonoco ThermoSafe Company Information
- 8.1.2 Sonoco ThermoSafe Business Overview
- 8.1.3 Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Product Portfolio
- 8.1.5 Sonoco ThermoSafe Recent Developments
- 8.2 Hazgo
- 8.2.1 Hazgo Company Information
- 8.2.2 Hazgo Business Overview
- 8.2.3 Hazgo Passive Temperature Controlled Packaging in Pharma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Hazgo Passive Temperature Controlled Packaging in Pharma Product Portfolio
- 8.2.5 Hazgo Recent Developments
- 8.3 Cold Chain Technologies
- 8.3.1 Cold Chain Technologies Company Information
- 8.3.2 Cold Chain Technologies Business Overview
- 8.3.3 Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Product Portfolio
- 8.3.5 Cold Chain Technologies Recent Developments
- 8.4 Marken
- 8.4.1 Marken Company Information
- 8.4.2 Marken Business Overview
- 8.4.3 Marken Passive Temperature Controlled Packaging in Pharma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Marken Passive Temperature Controlled Packaging in Pharma Product Portfolio
- 8.4.5 Marken Recent Developments
- 8.5 Jarden Life Sciences
- 8.5.1 Jarden Life Sciences Company Information
- 8.5.2 Jarden Life Sciences Business Overview
- 8.5.3 Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Product Portfolio
- 8.5.5 Jarden Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Passive Temperature Controlled Packaging in Pharma Value Chain Analysis
- 9.1.1 Passive Temperature Controlled Packaging in Pharma Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Passive Temperature Controlled Packaging in Pharma Production Mode & Process
- 9.2 Passive Temperature Controlled Packaging in Pharma Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Passive Temperature Controlled Packaging in Pharma Distributors
- 9.2.3 Passive Temperature Controlled Packaging in Pharma Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst